Presented at Respiratory Drug Delivery 2024, the Nasdepi Canine Study Indicates the Dry Powder Nasal Solution Provides a Faster and More Effective Treatment for Anaphylaxis as a Result of Severe Allergies
Read MoreBy leveraging advanced natural language processing and machine learning capabilities, Ethical’s new AI-powered conversational documents search tool reduces the time and effort required to find critical information and enhances the overall efficiency and quality of the endpoint adjudication process.
Read MoreNew innovative clinical services to help pharmaceutical and biotech companies improve patient recruitment, reduce the risk of adverse reactions, and refine the drug development process.
Read MoreFlorence Healthcare, the leading provider of Site Enablement Platforms for clinical trials, announced today that it has acquired VersaTrial, a cutting-edge clinical trial solutions provider.
Read MorePA-based clinical technology provider assisTek has announced new features to its upcoming software release, including AI Integration, a Proprietary OS, SSO & Remote Provisioning, to add to its growing suite of eCOA & ePRO solutions.
Read MoreThe company plans to leverage its platform technology to improve access and quality to medical EEG testing and to enable and improve adjacent biomedical research and clinical trials.
Read More"React19" partners with closed-loop care coordination and referral platform "CrossTx" and biomedical-focused media network "TrialSite" to develop the first ever provider, social supports, and mental health network for the vaccine-injured across the United States with an eye on international expansion.
Read MoreAll-new Yunuverse cloud community capabilities, now standard on the Yunu platform, make it possible for over 1,000 on-demand specialty-trained radiologists, technologists, and study staff to be invited and instantly participate in any of the 4,000 in-flight imaging clinical trials running on the system today. Cancer centers may now extend the reach of trial programs to satellite sites and imaging centers, improving patient access to sophisticated oncology trials.
Read MoreNew multiyear collaboration between Florence Healthcare and IQVIA to ensure research sites participating in IQVIA studies have access to best-in-class site enablement technology to streamline operations and power remote connectivity.
Read MoreClinical Research Division to Offer Full-Service Support, Removing Barriers to Kidney Care Innovation by Providing Access to Large Patient Populations, Trial-Ready Sites, Principal Investigators
Read MoreGerman-based biotechnology company BioNTech will establish a clinical scale research mRNA manufacturing facility in Australia, following an in-principle letter of intent signed with the Victorian Government.
Read MoreMayo Clinic will onboard Triall's blockchain-integrated eClinical platform to embed verifiable data integrity into a multi-center pulmonary arterial hypertension trial that includes 10 research sites and 500+ patients across the United States.
Read MoreEthical GmbH releases a new version of eReconciliation® that uses artificial intelligence (AI) to improve the performance of the software automation engine. This third version of eReconciliation® continues to optimize time spent on SAE data reconciliation and reduce the risk of errors and omissions, particularly when high volumes of data or heterogeneous environments are involved.
Read MoreAbstract: Triall will onboard the globally deployed eClinical platform of Crucial Data Solutions into the Triall ecosystem, offering clinical researchers around the world with access to Triall's blockchain APIs that strengthen clinical trial data integrity, auditability, and interoperability.
Read More